BackgroundCheck.run
Search For

Stephen L Comeau, 5522 Tilton St, Nashua, NH 03063

Related to:
Oliver Desrosiers Tylre Comeau 26 Michelle Comeau 50 Nicholas Comeau

Stephen Comeau Phones & Addresses

71 Spit Brook Rd, Nashua, NH 03060   

Ridgewood, NJ   

Arlington, MA   

Hudson, NH   

10 Summer St, Malden, MA 02148   

Waltham, MA   

5 Turnbridge Dr, Nashua, NH 03062   

Get Report
Control this profile

Mentions for Stephen L Comeau

Career records & work history

Lawyers & Attorneys

Stephen Comeau Photo 1

Stephen Comeau - Lawyer

Specialties:
Business/Corporations, Small Business Law, Small Business Corporations, Wills, Business Estate Planning, Business Transactions, Commercial Transactions, Mergers and Acquisitions, Business Acquisitions, Business Formation, Business Start-Ups, Business Valuation, Construction Law, Commercial, Contracts & Agreements, Limited Liability Company (LLC)
ISLN:
908257131
Admitted:
1979
University:
New Mexico State University; New Mexico State University; New Mexico State University; New Mexico State University, B.A.; New Mexico State University, B.A.; New Mexico State University, B.A.; New Mexico State University, 1976; New Mexico State University, 1976; New Mexico State University, 1976
Law School:
University of New Mexico, J.D., 1979

Medicine Doctors

Stephen G. Comeau

Specialties:
Nephrology
Work:
Northeast Nephrology
417 State St STE 321, Bangor, ME 04401
207-9738833 (phone) 207-9738836 (fax)
Cary Medical Specialty Services
163 Van Buren Rd STE 1, Caribou, ME 04736
207-4981394 (phone) 207-4981669 (fax)
Education:
Medical School
Saint Louis University School of Medicine
Graduated: 1996
Procedures:
Dialysis Procedures
Conditions:
Acute Renal Failure, Anemia, Atherosclerosis, Atrial Fibrillation and Atrial Flutter, Calculus of the Urinary System, Chronic Renal Disease, Congenital Anomalies of the Heart, Dermatitis, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Gout, Heart Failure, Hypertension (HTN), Hyperthyroidism, Hypothyroidism, Inflammatory Bowel Disease (IBD), Iron Deficiency Anemia, Ischemic Heart Disease, Ischemic Stroke, Kidney Cancer, Nephrotic Syndrome, Obstructive Sleep Apnea, Overweight and Obesity, Peripheral Nerve Disorders, Poisoning by Drugs, Meds, or Biological Substances, Systemic Lupus Erythematosus, Vitamin D Deficiency
Languages:
English, French
Description:
Dr. Comeau graduated from the Saint Louis University School of Medicine in 1996. He works in Caribou, ME and 1 other location and specializes in Nephrology. Dr. Comeau is affiliated with Cary Medical Center, Eastern Maine Medical Center and St Joseph Hospital.

License Records

Stephen Gerard Comeau

Licenses:
License #: MT038957T - Expired
Category: Medicine
Type: Graduate Medical Trainee

Stephen Comeau resumes & CV records

Resumes

Stephen Comeau Photo 36

Project & Product Management Consultant

Location:
Greater New York City Area
Industry:
Telecommunications
Stephen Comeau Photo 37

Branch Manager At Hsbc

Location:
Greater New York City Area
Industry:
Banking
Stephen Comeau Photo 38

Stephen Comeau

Location:
Greater New York City Area
Industry:
Higher Education
Stephen Comeau Photo 39

Stephen Comeau

Location:
United States
Stephen Comeau Photo 40

Client Finance Manager At Ibm

Location:
United States
Industry:
Information Technology and Services
Stephen Comeau Photo 41

Account Advisor At Arista Air Conditioning

Location:
Greater New York City Area
Industry:
Mechanical or Industrial Engineering
Stephen Comeau Photo 42

Biology Professor Massasoit Community College

Position:
ABE III Teacher at Training Resources of America, Biology Professor Massasoit Community College at Massasoit Community College
Location:
United States
Industry:
Professional Training & Coaching
Work:
Training Resources of America
ABE III Teacher Massasoit Community College - Brockton, MA since Sep 2007
Biology Professor Massasoit Community College

Publications & IP owners

Us Patents

Anti-Plasma Kallikrein Antibodies

US Patent:
2023000, Jan 5, 2023
Filed:
Mar 2, 2022
Appl. No.:
17/684460
Inventors:
- Osaka, JP
Jon A. Kenniston - Hingham MA, US
Stephen R. Comeau - Avon NY, US
Assignee:
Takeda Pharmaceutical Company Limited - Osaka
International Classification:
C07K 16/40
Abstract:
Disclosed herein are antibodies capable of binding to plasma kallikrein and inhibit its activity. Such antibodies interact with one or more critical residues in the catalytic domain of the plasma kallikrein. The antibodies may also contain specific heavy chain complementarity determining region 3 (CDRs) motifs and optionally specific residues at certain positions within both the heavy chain variable region and the light chain variable region.

Anti-Plasma Kallikrein Antibodies

US Patent:
2019018, Jun 20, 2019
Filed:
Nov 26, 2018
Appl. No.:
16/199453
Inventors:
- Lexington MA, US
Jon A. Kenniston - Hingham MA, US
Stephen R. Comeau - Avon NY, US
Assignee:
Dyax Corp. - Lexington MA
International Classification:
C07K 16/40
Abstract:
Disclosed herein are antibodies capable of binding to plasma kallikrein and inhibit its activity. Such antibodies interact with one or more critical residues in the catalytic domain of the plasma kallikrein. The antibodies may also contain specific heavy chain complementarity determining region 3 (CDRs) motifs and optionally specific residues at certain positions within both the heavy chain variable region and the light chain variable region.

A Monoclonal Antibody Inhibitor Of Factor Xiia

US Patent:
2019000, Jan 3, 2019
Filed:
Jul 21, 2016
Appl. No.:
15/746048
Inventors:
- Burlington MA, US
Jon A. Kenniston - Hingham MA, US
Andrew Nixon - Hanover MA, US
Daniel J. Sexton - Melrose MA, US
Stephen R. Comeau - Avon NY, US
Burt Adelman - Concord MA, US
Assignee:
Dyax Corp. - Burlington MA
International Classification:
C07K 16/36
Abstract:
Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.

Anti-Plasma Kallikrein Antibodies

US Patent:
2016001, Jan 21, 2016
Filed:
Mar 14, 2014
Appl. No.:
14/773766
Inventors:
- Burlington MA, US
Jon A. KENNISTON - Hingham MA, US
Stephen R. COMEAU - Chelmsford MA, US
Assignee:
Dyax Corp. - Burlington MA
International Classification:
C07K 16/40
Abstract:
Disclosed herein are antibodies capable of binding to plasma kallikrein and inhibit its activity. Such antibodies interact with one or more critical residues in the catalytic domain of the plasma kallikrein. The antibodies may also contain specific heavy chain complementarity determining region 3 (CDRs) motifs and optionally specific residues at certain positions within both the heavy chain variable region and the light chain variable region.

Possible Relatives

David L Comeau  Dawn Comeau  Deanna M Comeau  Daniel J Comeau  Aaron L Comeau  Denise A Comeau  Danielle Comeau  Stephen H Last  Stephen V Johnson  Stephen Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.